OMER

Omeros Corporation News Headlines

$11.98
*  
0.13
 negative 
1.1%
Get OMER Alerts
*Delayed - data as of Apr. 24, 2014 12:50 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OMER Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Will St. Jude Medical (STJ) Surprise This Earnings Season? - Analyst Blog
4/15/2014 4:32:01 PM - Zacks.com

Omeros To Present At Needham Healthcare Conference; Webcast At 3:00 PM ET
4/9/2014 2:00:00 PM - RTT News

Sector Update: Healthcare Shares Mixed Pre-Market; Vivus Sinks 5% on Piper Jaffray Downgrade
4/3/2014 8:35:37 AM - MT Newswires

Sector Update: Healthcares
4/3/2014 8:30:19 AM - MT Newswires

FDA Clears Omeros' IND To Evaluate OMS721 In Thrombotic Microangiopathies
4/3/2014 7:16:00 AM - RTT News

Omeros To Present At Biotech Industry Conference ; Webcast At 9:00 AM ET
3/28/2014 8:00:00 AM - RTT News

Additional Positive Data on Omeros Treatment - Analyst Blog
3/10/2014 6:50:01 PM - Zacks.com

Sector Update: Healthcare Shares Higher Pre-Market; Omeros Gains 5% on Positive Results From Schizophrenia Treatment Trial
3/7/2014 9:37:45 AM - MT Newswires

Sector Update: Healthcare
3/7/2014 9:37:24 AM - MT Newswires

Omeros Phase 2a Trial Of OMS824 Yields More Positive Results
3/6/2014 7:32:00 AM - RTT News

Omeros Files IND Application With FDA To Initiate Phase 2 For OMS721
3/4/2014 7:37:00 AM - RTT News

Cramer's Lightning Round - No Growth In Fertilizer (2/24/14)
2/25/2014 6:27:00 AM - Seeking Alpha

Omeros Doses First Patient in a Study - Analyst Blog
2/20/2014 7:00:01 PM - Zacks.com

Omeros Announces Dosing Of First Patient In Second OMS824 Phase 2 Trial
2/19/2014 7:12:00 AM - RTT News

Additional Data on Omeros' OMS824 - Analyst Blog
2/14/2014 5:30:01 PM - Zacks.com

Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha

Omeros: FDA Grants Fast Track Status To OMS824 Huntington's Disease Program
2/5/2014 7:26:00 AM - RTT News

Positive Data on Omeros' OMS721 - Analyst Blog
2/4/2014 6:10:01 PM - Zacks.com

DXCM Gets FDA Nod, MRK Breathes Easy, Neovasc Takes Heart, VRX Opens Wallet
2/4/2014 4:08:00 AM - RTT News

Omeros Reports Positive Data After Dosing In Phase 1 Trial With OMS721
2/3/2014 7:13:00 AM - RTT News

Positive Data on Omeros' OMS824 - Analyst Blog
1/30/2014 7:20:01 PM - Zacks.com

Omeros: When To Be Cautious?
12/23/2013 1:22:00 PM - Seeking Alpha

Orphan Drug Designation for Omeros' OMS721 - Analyst Blog
12/19/2013 12:17:32 PM - Zacks.com

Omeros Corp. (OMER) Jumps: Stock Rises 18.1% - Tale of the Tape
12/19/2013 10:11:01 AM - Zacks.com

Data on Omeros' Omidria - Analyst Blog
11/21/2013 6:06:19 PM - Zacks.com